Goldman Sachs Upgrades Seattle Genetics (SGEN) to Neutral
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Goldman Sachs upgraded Seattle Genetics (NASDAQ: SGEN) from Sell to Neutral with a price target of $47.00 (from $30.00).
Shares of Seattle Genetics closed at $54.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amazon (AMZN) PT Raised to $1050 at Goldman Sachs Into Q3 Print
- Susquehanna Cuts Price Target on KLA-Tencor (KLAC) Following Strong 1Q
- Goldman Sachs Starts Hertz Global (HTZ) at 'Sell' and Avis Budget (CAR) at 'Neutral'
Create E-mail Alert Related CategoriesAnalyst PT Change, Upgrades
Related EntitiesGoldman Sachs
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!